HSDT vs. ^GSPC

In the year-to-date period, HSDT achieves a -54.05% return, which is significantly lower than ^GSPC's -3.93% return. Over the past 10 years, HSDT has underperformed ^GSPC with an annualized return of -68.18%, while ^GSPC has yielded a comparatively higher 10.35% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Helius Medical Technologies, Inc. (HSDT) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current HSDT Sharpe Ratio is -0.59, which is lower than the ^GSPC Sharpe Ratio of 0.65. The chart below compares the historical Sharpe Ratios of HSDT and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

The maximum HSDT drawdown since its inception was -100.00%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for HSDT and ^GSPC. For additional features, visit the drawdowns tool.

Helius Medical Technologies, Inc. (HSDT) has a higher volatility of 35.11% compared to S&P 500 (^GSPC) at 13.20%. This indicates that HSDT's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.